Studies have reported the upregulation of MTA2 in many types of cancers, such as gastric cancer 14, 15, breast cancer 11, and non-small-cell lung carcinoma (NSCLC) 16. This evidence concerns the gene MTA2 and non-small cell lung carcinoma.